Hepatoblastoma screening of low-birthweight children cost effective in US

    This is a preview of subscription content, log in to check access.

    Reference

    1. MacDonell-Yilmaz R, et al. Cost-effectiveness Analysis of Screening Extremely Low Birthweight Children for Hepatoblastoma Using Serum Alpha-fetoprotein. Journal of Pediatrics : 26 May 2020. Available from: URL: http://doi.org/10.1016/j.jpeds.2020.05.041

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Hepatoblastoma screening of low-birthweight children cost effective in US. PharmacoEcon Outcomes News 855, 17 (2020). https://doi.org/10.1007/s40274-020-6882-6

    Download citation